László Vécsei

professor

Szent-Györgyi Albert Medical School, University of Szeged

Hungary

Research Interests

Explore related searches

Professors in Hungary

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor László Vécsei is a faculty member at the Szent-Györgyi Albert Medical School, University of Szeged, Hungary. His research primarily focuses on the neurobiological mechanisms underlying migraine treatment, neuropsychiatric disorders, and the kynurenine pathway. Recent publications include investigations into the effects of transcranial stimulation on post-stroke depression and anxiety, as well as the role of bioactive kynurenines as neuroprotective agents. Professor Vécsei also explores novel therapeutic approaches in conditions such as multiple sclerosis and generalized myasthenia gravis.

Articles (12)

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

HUNGARY

View details

Diego Lopergolo

University of Siena

ITALY

View details

Gyongyi Horvath

Professor, Head of Laboratory forBehavioral-Pharmacology

Szent-Györgyi Albert Medical School, University of Szeged

HUNGARY

View details

Masaru Tanaka

University of Szeged

HUNGARY

View details

Eleonóra Spekker

Szent-Györgyi Albert Medical School, University of Szeged

HUNGARY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

László Vécsei

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

The effect of transcranial direct current stimulation and inhibitory control training on depression and anxiety among post-stroke individuals

From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment

CGRP and CGRP-Receptor as Targets of Migraine Therapy: Brain Prize-2021

Modelling the neurodevelopmental pathogenesis in neuropsychiatric disorders. Bioactive kynurenines and their analogues as neuroprotective agents—in celebration of 80th birthday of Professor Peter Riederer

B-sejt-depletio a sclerosis mulitplex terápiájában: új szereplő az ofatumumab

Kynurenic acid and kynurenine aminotransferase are potential biomarkers of early neurological improvement after thrombolytic therapy: A pilot study

Identification of disease- and headache-specific mediators and pathways in migraine using blood transcriptomic and metabolomic analysis.

A Potential Interface between the Kynurenine Pathway and Autonomic Imbalance in Schizophrenia.

Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study.

Monitoring the kynurenine system: Concentrations, ratios or what else?

Kynurenic Acid and Its Synthetic Derivatives Protect Against Sepsis-Associated Neutrophil Activation and Brain Mitochondrial Dysfunction in Rats.

Co-Players in Chronic Pain: Neuroinflammation and the Tryptophan-Kynurenine Metabolic Pathway.

Collaborators (10)

Gabriella Kekesi

Peter Klivenyi

Adam Annus

Tamas Janaky

Bálint Lőrinczi

Attila Rutai

Diego Lopergolo

Gyongyi Horvath

Masaru Tanaka

Eleonóra Spekker

Make your next move.